XML 65 R57.htm IDEA: XBRL DOCUMENT v3.25.2
Significant Agreements (Additional Information) (Details) - USD ($)
$ in Millions
12 Months Ended
Nov. 15, 2024
Dec. 31, 2023
Dec. 21, 2023
Oct. 31, 2023
US        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Split Profits and Losses Percentage 40.00%      
AbbVie Option Agreement [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Non refundable payment     $ 5.0 $ 1.0
Allowable Expenses Reimbursed Percenage 60.00%      
Upfront Cash Payment $ 100.0      
Milestone payments $ 100.0      
Split Profits and Losses Percentage 60.00%      
Revenues   $ 0.0    
Deferred collaboration revenue   6.0    
Transaction price   $ 6.0    
AbbVie Option Agreement [Member] | Maximum [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Milestone payments $ 300.0